Replies to post #88668 on Biotech Values

[DewDiligence]

As far as showing you data, I can only tell you what is the perception out there from having talked to dozens of infectious disease specialists.

In other words, you don’t have any data showing that ritonavir boosting makes a big difference in PI resistance. That’s what I figured.

In any case, if we can agree that the HIV market is moving away from PI’s, I’m happy because that’s the essence of the discussion in #msg-45207265. Regards, Dew